Skip to main content
. Author manuscript; available in PMC: 2014 Nov 21.
Published in final edited form as: Circulation. 2010 Jul 19;122(5):507–516. doi: 10.1161/CIRCULATIONAHA.109.921692

Table 1.

Diagnostic and Conduit-Related Data in 136 Patients Undergoing Catheterization

Original cardiac diagnosis, n (%)
 Tetralogy of Fallot 65 (48)
  Pulmonary atresia 40
  Pulmonary stenosis 19
  Absent pulmonary valve 5
  Atrioventricular canal 1
 Aortic valve disease after Ross operation 28 (21)
 Transposition of the great arteries 15 (11)
 Truncus arteriosus 14 (10)
 Double-outlet right ventricle 8 (6)
 Valvar pulmonary stenosis 3 (2)
 Other 2 (1)
NYHA functional class, n (%)
 I 22 (16)
 II 91 (67)
 III 22 (16)
 IV 1 (1)
Type of conduit or pulmonary valve, n (%)
 Homograft 103 (76)
 Bioprosthetic valve or conduit* 26 (19)
 Synthetic 7 (5)
Previously placed conduit stent, n (%)
 No 100 (74)
 Single stent 23 (17)
 Multiple stents 12 (9)
 No report 1 (1)
Median (range) conduit/valve diameter at the time of surgical implantation, mm 21 (16–28)
Number of prior surgical conduits
 Median (range), n 1 (1–5)
 >1, n (%) 65 (48)

Data reflect the number of patients and the percentage of the catheterized cohort (n=136) or the median and range as appropriate.

*

Includes bioprosthetic valves, conduits with integrated bioprosthetic valves, and nonhomograft biological conduits (eg, Contegra).